Paraneoplastic syndromes of gynecologic neoplasms

Journal of Clinical Oncology

Volumn 15, Issue 3, 1997, Pages 1272-1282

  Ashour, A A ^a   Verschraegen, C F ^a   Kudelka, A P ^a   Kavanagh, J J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACANTHOSIS NIGRICANS; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CEREBELLUM DEGENERATION; CUSHING DISEASE; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; EATON LAMBERT SYNDROME; ERYTHROCYTOSIS; FEMALE; GYNECOLOGIC CANCER; HUMAN; HYPERCALCEMIA; MEDICAL INFORMATION; NEUROLOGIC DISEASE; OPSOCLONUS; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; RETINA DEGENERATION; TERATOMA; THROMBOPHLEBITIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; ZOLLINGER ELLISON SYNDROME;

EID: 0031051099     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.3.1272     Document Type: Article

References (138)

1. Sindic CJ, Andersson M, Boucquey D, et al: Anti-Purkinje's cells antibodies in two cases of paraneoplastic cerebellar degeneration. Acta Neurol Belg 93:65-77, 1993
2. Dalmau J, Posner JB: Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu: anti-Ri): The case for a nomenclature based on antibody and antigen specificity. Neurology 44:2241-2246, 1994
3. Tomimoto H, Brengman JM, Yanagihara T: Paraneoplastic cerebellar degeneration with a circulating antibody against neurons and non-neuronal cells. Acta Neuropathol 86:206-211, 1993
4. Nardelli E, Curro-Dossi B, Rizzuto N, et al: Autoimmune paraneoplastic cerebellar degeneration: Immunohistological localization of antibody binding sites. Clin Neurol Neurosurg 97:89-94, 1995
5. Hetzel DJ, Stanhope CR, O'Neill BP, et al: Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje's cell antibodies and limited in metastatic volume. Mayo Clin Proc 65:1558-1563, 1990
6. Colangelo U, Nuccetelli F, Assetta M, et al: Subacute cerebellar degeneration in cystadenopapillary carcinoma of the ovaries. Minerva Med 78:1397-1398, 1987
7. Kawano T, Kawakami S, Katabuchi H, et al: A case of carcinoma of the uterine cervix accompanied with paraneoplastic cerebellar degeneration. Nippon Sanka Fujinka Gakkai Zasshi 45:383-386, 1993
8. Hudson CN, Curling M, Postsides P, et al: Paraneoplastic syndromes in patients with ovarian neoplasia. J R Soc Med 86:202-205, 1993
9. Posner JB, Furneaux HM: Paraneoplastic syndromes, in Waksman BH (ed): Immunologic Mechanisms in Neurologic and Psychiatric Disease. New York, NY, Raven, 1990, pp 187-201
10. McLellan R, Currie JL, Royal W, et al: Ovarian carcinoma and paraneoplastic cerebellar degeneration. Obstet Gynecol 72:922-925, 1988
11. Graus F, Illa I, Agusti M, et al: Effect of intraventricular injection of an anti-Purkinje's cell antibody (anti-Yo) in a guinea pig model. J Neurol 106:82-87, 1991
12. Sakai K, Mitchell DJ, Tsukamoto T, et al: Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration. Ann Neurol 28:692-698, 1990
13. Tarraza HM, McInnis S, Meltzer SE, et al: Isolated cerebellar metastasis from ovarian carcinoma. Case report and review of the literature. Eur J Gynaecol Oncol 13:322-325, 1992
14. Baker JM, Gallup DG: Cerebellar metastases from epithelial ovarian carcinoma. A case report. J Reprod Med 32:225-229, 1987
15. Gottlieb JA , Luce JK: Cerebellar ataxia with weekly 5-fluorouracil administration. Lancet 1:138-139, 1971
16. Posner JB: Paraneoplastic syndromes, in Posner JB (ed): Neurologic Complications of Cancer. Philadelphia, PA, Davis, 1995, pp 353-371
17. Cocconi G, Ceci G, Juvarra G, et al: Successful treatment of subacute cerebellar degeneration in ovarian carcinoma with plasmapheresis. A case report. Cancer 56:2318-2320, 1985
18. Sliwa JA, Thatcher S, Jet J: Paraneoplastic subacute cerebellar degeneration: Functional improvement and the role of rehabilitation. Arch Phys Med Rehabil 75:355-357, 1994
19. Kalkman PH, Allan S, Lain WJ, et al: Magnetic resonance imaging of limbic encephalitis. Can Assoc Radiol J 44:121-124, 1993
20. Huang SC, Hsieh CY, Yao YT, et al: Encephalitis following radical hysterectomy for cervical cancer with latent pelvic tuberculosis as an incidental finding: Report of a case. Taiwan I Hsueh Hui Tsa Chih 87:112-115, 1988
21. Dayan AD, Bhatti I, Gostling JV: Encephalitis due to herpes simplex in a patient with treated carcinoma of the uterus. Speculations about herpes simplex as a cause of carcinomatous encephalitis. Neurology 6:609-613, 1967
22. Verschraegen CF, Conrad CA, Hong WH: Subacute encephalopathic toxicity of cisplatin. Lung Cancer 13:305-309, 1995
23. Kaniecki R, Morris J: Reversible paraneoplastic limbic encephalitis. J Neurol 23:2418, 1993
24. Keltner JL, Roth AM, Chang RS: Photoreceptor degeneration. Possible autoimmune disorder. Arch Ophthalmol 101:564-569, 1983
25. Cogan DG, Kuwabara T, Currie J, et al: Paraneoplastic retinopathy simulating cone dystrophy with achromatopsia. Klin Monatsbl Augenheilkd 197:156-158, 1990
26. Crofts JW, Bachynski BN, Odel JG: Visual paraneoplastic syndrome associated with undifferentiated endometrial carcinoma. Can J Ophthalmol 23:128-132, 1988
27. Polans AS: A photoreceptor calcium-binding protein is recognized by autoantibodies obtained from patients with cancer associated retinopathy. J Cell Biol 112:981, 1991
28. Luque FA, Furneaux HM, Erziger R, et al: Anti-Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 29:241-251, 1991
29. Scholz J, Vieregge P, Ruff C: Paraneoplastic opsoclonusmyoclonus syndrome in metastatic ovarian carcinoma. J Neurol Neurosur Psychiatry 57:763-764, 1994
30. Budde-Steffen C, Anderson NE, Rosenblum MK, et al: An antineuronal autoantibody in paraneoplastic opsoclonus. Ann Neurol 23:528-531, 1988
31. Vilchez JJ, Lago A, Burguera JA, et al: Chlormethiazole in the management of the opsoclonus-myoclonus syndrome. J Int Med Res 22:55-62, 1994
32. Nitschke M, Hochberg F, Dropcho E: Improvement of paraneoplastic opsoclonus-myoclonus after protein a column therapy. N Engl J Med 32:192, 1995
33. Lennon VA, Kryzer TJ, Griesmann GE, et al: Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 332:1467-1474, 1995
34. Sutton GP, Siemers E, Stehman FB, et al: Eaton-Lambert syndrome as a harbinger of recurrent small-cell carcinoma of the cervix with improvement after combination chemotherapy. Obstet Gynecol 72:516-518, 1988
35. Cavaletti G, Bogliun G, Marzorati L, et al: The incidence and course of paraneoplastic neuropathy in women with epithelial ovarian cancer. J Neurol 238:371-374, 1991
36. Yamada M, Shintani S, Mitani K, et al: Peripheral neuropathy with predominantly motor manifestations in a patient with carcinoma of the uterus. J Neurol 235:368-370, 1988
37. Belluci S, Bosquet C, Boval B, et al: Association of autoimmune thrombocytopenic purpura, Grave's disease and ovarian carcinoma. Nouv Rev Fr Hematol 33:307-309, 1991
38. Hammond D, Winnick S: Paraneoplastic erythrocytosis and ectopic erythropoietins. Ann NY Acad Sci 230:219-227, 1974
39. Naets JP, Witte M, Delwiche F, et al: Polycythaemia and erythropoietin producing uterine fibromyoma. Scand J Haematol 19:75-78, 1977
40. Raj R , Lake Y: Polycythemia associated with leiomyoma of the uterus. Br J Obstet Gynaecol 99:923-927, 1992
41. Briggs ND, Katchy KC: Brenner tumor as encountered in a Southern Nigerian hospital. Int J Gynaecol Obstet 27:455-458, 1988
42. Montag TW, Murphy RE, Belinson JL: Virilizing malignant lipid cell tumor producing erythropoietin. Gynecol Oncol 19:98-103, 1984
43. Ghio R, Haupt E, Ratti M, et al: Erythrocytosis associated with a dermoid cyst of the ovary and erythropoietic activity of the tumor fluid. Scand J Haematol 27:70-74, 1981
44. Brewer CA, Adelson MD, Elder RC: Erythrocytosis associated with a placental-site trophoblastic tumor. Obstet Gynecol 79:846-849, 1992
45. Muechler EK: Testosterone-producing ovarian tumor associated with erythrocytosis, hyperuricemia, and recurrent deep vein thrombosis. Am J Obstet Gynecol 129:467-469, 1977
46. Desablens B, Steenkiste G, Boffa GA, et al: Polycythaemia and uterine fibroma. A case with in vitro demonstration of an erythropoietic activity in the tumor. Semin Hop 56:1138-1144, 1980
47. Young RH: New and unusual aspects of ovarian germ cell tumors. Am J Surg Pathol 17:1210-1224, 1993
48. Dawson MA, Talbert W, Yarbro JW: Hemolytic anemia associated with an ovarian tumor. Am J Med 50:552-556, 1971
49. Bar BM, Reijnders FJ, Keuning JJ, et al: Primary malignant lymphoma of the uterine cervix associated with cold-reacting autoantibody-mediated hemolytic anemia. Acta Haematol 75:232-235, 1986
50. Pogliani Em, Fowst C, Maff'e P, et al: CNS metastasis in ovarian cancer with microangiopathic hemolytic anemia associated with diffuse intravascular coagulation. Tumori 74:731-736, 1988
51. Antman KH, Skarin AT, Mayer RJ, et al: Microangiopathic hemolytic anemia and cancer: A review. Medicine 12:377-384, 1979
52. Miller SP, Sanchez-Avalos J, Stefanski T: Coagulation disorders in cancer. I. Clinical and laboratory studies. Cancer 20:1452-1465, 1967
53. Schafer AI: The hypercoagulable states. Ann Intern Med 102:814-828, 1985
54. Nand S, Gross FS, Salgia R, et al: Homeostatic abnormalities in untreated cancer: Incidence and correlation with thrombotic and hemorrhagic complications. J Clin Oncol 5:1998-2003, 1987
55. Gralnick HR, Abrell BA: Studies of the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukemia. Br J Haematol 24:89-99, 1973
56. Rapaport SI: Blood coagulation and its alterations in hemorrhagic and thrombotic disorders. West J Med 158:153-161, 1993
57. Donovan JT, Veroniis DK, Powell JL, et al: Cytoreductive surgery for ovarian cancer with the Cavitron ultrasonic surgical aspirator and the development of disseminated intravascular coagulation. Obstet Gynecol 83:1011-1014, 1994
58. Huberman RP, Fon GT, Bein ME: Benign molar pregnancies: Pulmonary complications. Am J Roentgenol 138:71-74, 1982
59. Eckstein RP, Paradinas FJ, Bagshawe KD: Placental site trophoblastic tumor (trophoblastic pseudotumor): A study of four cases requiring hysterectomy including one fatal case. Histopathology 6:211-226, 1982
60. Caputo R, Kanbour-Shakir A: Chronic disseminated intravascular coagulation caused by a uterine leiomyoma. A case report. J Reprod Med 38:737-740, 1993
61. Sacks PC, Hoyne PM: Disseminated intravascular coagulation, hemolytic anemia, and acute renal failure associated with extensive multiple myomectomy. Obstet Gynecol 79:835-838, 1992
62. Tsakok FH: Review on coagulation in trophoblastic disease. Ann Acad Med Singapore 11:555-560, 1982
63. Shinagawa S, Kagiya A, Kikuchi M, et al: Gynecological malignancies and disseminated intravascular coagulation. Nippon Sanka Fujinka Gakkai Zasshi 36:108-112, 1984
64. Bedikian A, Valdivieso M, Luna M, et al: Nonbacterial thrombotic endocarditis in cancer patients: Comparison of characteristics of patients with and without concomitant disseminated intravascular coagulation. Med Pediatr Oncol 4:149-157, 1978
65. Glass JP: The diagnosis and treatment of stroke in a patient with cancer: Nonbacterial thrombotic endocarditis: A case report and review. Clin Neurol Neurosurg 95:315-318, 1993
66. Delgado G, Smith JP: Gynecological malignancy associated with nonbacterial thrombotic endocarditis. Gynecol Oncol 3:205-209, 1975
67. Woimant F, Moulinier L, Lecoz P, et al: Cerebral ischemic accidents and chronic disseminated intravascular coagulation of cancerous origin. Rev Neurol 144:120-124, 1988
68. Koopman J, Haverkate F, Koppert P: New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody. J Lab Clin Med 109:75-84, 1987
69. Maggino T, Paternoster D, Valente S, et al: Fibrinolysis in ovarian cancer. Eur J Gynaecol Oncol 2:70-72, 1981
70. Bell WR, Starksen NF, Tang S, et al: Trousseau's syndrome. Devastating coagulopathy in the absence of heparin. Am J Med 79:423-430, 1985
71. Miller B , Heilmann L: Hemorrheological parameters in patients with gynecologic malignancies. Gynecol Oncol 33:177-181, 1989
72. Kragt H, Bouma J, Aalders JG: Anticoagulants and the formation of lymphocysts after pelvic lymphadenectomy in gynecologic and oncologic operations. Surg Gynecol Obstet 162:361-364, 1986
73. Dvork HF: Abnormalities of hemostatis in malignant disease, in Colman RW, Hirsh J, Marder VJ, et al (eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice (ed 3). Philadelphia, PA, Lippincott, 1994, pp 357-388
74. Adamson AS, Littlewood TJ, Poston GJ, et al: Malignancy presenting as peripheral venous gangrene. J R Soc Med 81:609-610, 1988
75. Feigen M: Fatal veno-occlusive disease of the liver associated with herbal tea consumption and radiation. Aust NZ J Med 14:61-62, 1984
76. Reichelt HG: Partial Budd-Chiari syndrome with Zahn infarct of the liver in venous transmitted tumor thrombosis of a uterine cancer. Roentgenblatter 38:345-347, 1985
77. Puleo JG, Clarke-Pearson DL, Smith EB, et al: Superior vena cava syndrome associated with gynecologic malignancy. Gynecol Oncol 23:59-64, 1986
78. Contrino J, Hair GA, Schmeizl MA, et al: In situ characterization of antigenic and functional tissue factor expression in human tumors utilizing monoclonal antibodies and recombinant factor Vila as probes. Am J Pathol 145:1315-1322, 1994
79. Mussoni L, Conforti G, Gambacorti-Passerini C, et al: Procoagulant and fibrinolytic activity in human ovarian carcinoma cells in culture. Eur J Clin Oncol 22:373-376, 1985
80. Grignani G, Fallanga A, Pochiarini L, et al: Human breast and colon carcinoma express cysteine protease activities with platelet aggregation and procoagulant properties. Int J Cancer 42:554-557, 1988
81. Van De Water L, Tracy PB, Aronson D, et al: Tumor cell generation of thrombin via functional prothrombinase assembly. Cancer Res 45:5521-5525, 1985
82. Wagman L, Galli R: Vena caval filtration in an oncologic population. Proc Am Soc Clin Oncol 10:A1197, 1991 (abstr)
83. Dalakas MC, Shuman MA, Corash L, et al: Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325:1487, 1994
84. Talbott JH: Acute dermatomyositis-polymyositis and malignancy. Semin Arthritis Rheum 6:305-360, 1977
85. Cherin P, Piette JC, Herson S, et al: Dermatomyositis and ovarian cancer: A report of 7 cases and literature review. J Rheumatol 20:1897-1899, 1993
86. Van Winter JT, Stanhope CR: Giant ovarian leiomyoma associated with ascites and polymyositis. Obstet Gynecol 80:560-563, 1992
87. Verducci MA, Malkasian GD Jr, Riedman SJ, et al: Gynecologic carcinoma associated with dermatomyositis-polymyositis. Obstet Gynecol 64:675-698, 1984
88. Scaling ST, Kaufman RH, Patten BM: Dermatomyositis and female malignancy. Obstet Gynecol 54:474-477, 1979
89. Armes JE, Rome R, Ostor AG, et al: A case of polymyositis and invasive squamous cell carcinoma of the uterine cervix. Aust NZ J Obstet Gynaecol 33:440-442, 1993
90. Makino H, Nagake Y, Moriwaki K, et al: Thrombotic thrombocytopenic purpura and myoglobinuric acute renal failure following radiation therapy in a patient with polymyositis and cervical cancer. Intern Med 34:24-27, 1995
91. McGill PE, Calman KC: Shoulder-hand syndrome in patients with ovarian carcinoma. Ann Rheum Dis 44:72, 1985
92. Taggart AJ, Iveson JM, Wright V: Shoulder-hand syndrome and symmetrical arthralgia in patients with tubo-ovarian carcinoma. Ann Rheum Dis 43:391-393, 1984
93. Champion GD, Saxon JA, Kossard S: The syndrome of palmar fasciitis and polyarthritis. J Rheumatol 14:1196-1198, 1987
94. Medsger TA, Dixon JA, Garwood VF: Palmar fasciitis and polyarthritis associated with ovarian carcinoma. Ann Intern Med 96:424-431, 1982
95. Pfinsgraff J, Buckingham RB, et al: Palmar fasciitis and arthritis with malignant neoplasms: A paraneoplastic syndrome. Semin Arthritis Rheum 16:118-126, 1986
96. Bunn Jr. PA, Ridgway EC: Paraneoplastic syndromes, in Devita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology (ed 4). Philadelphia, PA, Lippincott, 1993, pp 2028-2071
97. Bolonga C, Jorgensen C, Anaya JM, et al: Association of systemic lupus erythematosus and choriocarcinoma: A role of hormonal immunomodulation? Clin Exp Rheumatol 12:59-61, 1994
98. Lupez DM, Khamashta M, Pintado GV, et al: Malignancy in systemic lupus erythematosis: A report of five cases in a series of 96 patients. Lupus 12:377-380, 1993
99. Rigel DS, Jacobs MI: Malignant acanthosis nigricans: A review. J Dermatol Surg Oncol 6:923-927, 1980
100. Imperato-McGinley J, Peterson RE, Sturla E, et al: Primary amenorrhea associated with hirsutism, acanthosis nigricans, dermoid cysts of the ovaries and a new type of insulin resistance. Am J Med 65:389-395, 1978
101. Azizi E, Schneebaum S, Schewach-Millet M, et al: Generalized malignant acanthosis nigricans and primary fibrinolysis. Occurrence with squamous cell carcinoma of the uterine cervix. Arch Dermatol 110:955-956, 1982
102. Kuhl IC, Bakos L, Zampesi M, et al: The Leser-Trelat sign associated with carcinoma of the cervix uteri. Report of a case and review of the literature. Med Cutan Ibero Lat Am 14:251-254, 1986
103. McKenna KE, Hayes D, McMillan JC: Subacute cutaneous lupus erythematosus-like gyrate erythema and hypertrichosis lanuginosa acquisita associated with uterine adenocarcinoma. Br J Dermatol 127: 443-444, 1992
104. Kassis V, Kassis E, Keiding L, et al: Hypertrichosis lanuginosa acquisita associated with multiple malignancies. J Am Acad Dermatol 12:1106-1107, 1985
105. Samson MK, Buroker TR, Henderson MD, et al: Acquired hypertrichosis lanuginosa. Report of two new cases and a review of the literature. Cancer 36:1519-1521, 1975
106. Kaiser IH, Perry G, Yoonessi M: Acquired hypertrichosis lanuginosa associated with endometrial malignancy. Obstet Gynecol 47:479-482, 1976
107. Matias-Guiu X, Prat J, Young RH, et al: Human parathyroid hormone-related protein in ovarian small cell carcinoma. An immunohistochemical study. Cancer 73:1878-1881, 1994
108. Fleischhacker DS, Young RH: Dysgerminoma of the ovary associated with hypercalcemia. Gynecol Oncol 52:87-90, 1994
109. Taraszewski R, Rosman PM, Knight CA, et al: Small cell carcinoma of the ovary. Gynecol Oncol 41:149-151, 1991
110. Scully RE: Small cell carcinoma of hypercalcemic type. Int J Gynecol Pathol 12:148-152, 1993
111. Dharan M: Intraoperative cytology of small cell carcinoma of the ovary with hypercalcemia. A case report. Acta Cytol 37:61-66, 1993
112. Giebel SC, Stanhope CR, Malkasian GD, et al: Humoral hypercalcemia associated with a dysgerminoma. Mayo Clin Proc 67:966-968, 1992
113. Anstey A, Gowers L, Vass A, et al: Ovarian dysgerminoma presenting with hypercalcaemia. Case report and review of the literature. Br J Obstet Gynaecol 97:641-644, 1990
114. Buller R, Taylor K, Burg AC, et al: Paraneoplastic hypercalcemia associated with adenosquamous carcinoma of the endometrium. Gynecol Oncol 40:95-98, 1991
115. Hiller N, Sonnenblic M, Hershko C: Paraneoplastic hypercalcemia in endometrial carcinoma. Oncology 46:45-48, 1989
116. Dunne FP, Rollason T, Ratcliffe WA, et al: Parathyroid hormone-related protein gene expression in invasive cervical tumors. Cancer 74:83-89, 1994
117. Liapis H, Crouch EC, Roby J, et al: In situ localization of parathyroid hormone-like protein and mRNA in intraepithelial neoplasia and invasive carcinoma of the uterine cervix. Hum Pathol 24:1058-1066, 1993
118. Sachmechi I, Kalra J, Molho L, et al: Paraneoplastic hypercalcemia associated with uterine papillary serous carcinoma. Gynecol Oncol 58:378-382, 1995
119. Fukumoto S, Matsumoto T, Yamoto H, et al: Suppression of serum 1,25-dihydroxyvitamin D in humoral hypercalcemia of malignancy is caused by elaboration of a factor that inhibits renal 1,25-dihydroxyvitamin D3 production. Endocrinology 124:2057-2062, 1989
120. Eichhorn JH, Bell DA, Young RH, et al: DNA content and proliferative activity in ovarian small cell carcinomas of the hypercalcemic type. Implications for diagnosis, prognosis, and histogenesis. Am J Clin Pathol 98:579-586, 1992
121. Buono JP, Dechellote P, Glowaczower E, et al: Ploidy analysis in a case of ovarian small cell carcinoma. Ann Pathol 15:134-137, 1995
122. Reed WC: Small cell carcinoma of the ovary with hypercalcemia: Report of a case of survival without recurrence 5 years after surgery and chemotherapy. Gynecol Oncol 56:452-455, 1995
123. Connell WR, Price JD, Lowe DG, et al: Zollinger-Ellison syndrome caused by a mucinous cystadenocarcinoma of the ovary. Aust NZ J Med 23:520-521, 1991
124. Van Solinge WW, Odum L, Rehfeld JF: Ovarian cancers express and process progastrin. Cancer Res 53:1823-1828, 1993
125. Boixeda D, Lopez-San RA, Pascasio JM, et al: Zollinger-Ellison syndrome due to gastrin-secreting ovarian cystadenocarcinoma. Case report. Acta Chir Scand 156:409-410, 1990
126. Garcia-Villanueva M, Badia Figuerola N, et al: Zollinger-Ellison syndrome due to a borderline mucinous cystadenoma of the ovary. Obstet Gynecol 75:549-552, 1990
127. Primrose JN, Maloney M, Wells M, et al: Gastrin-producing ovarian mucinous cystadenomas: A cause of the Zollinger-Ellison syndrome. Surgery 104:830-833, 1988
128. Morgan DR, Wells M, MacDonald RC: Zollinger-Ellison syndrome due to a gastrin secreting ovarian mucinous cystadenoma. Case report. Br J Obstet Gynaecol 92:867-869, 1985
129. Maton PN, Mackem SM, Norton JA, et al: Ovarian carcinoma as a cause of Zollinger-Ellison syndrome. Natural history, secretory products, and response to provocative tests. Gastroenterology 97:468-471, 1989
130. Szyfelbein WM, Young RH, Scully RE: Cystic struma ovarii: A frequently unrecognized tumor. A report of 20 cases. Am Surg Pathol 18:785-788, 1994
131. Devaney K, Snyder R, Norris HJ, et al: Proliferative and histologically malignant struma ovarii: A clinicopathologic study of 54 cases. Int J Gynecol Pathol 12:333-343, 1993
132. Ayhan A, Yanik F, Tuncer R, et al: Struma ovarii. Int J Gynecol Obstet 42:143-146, 1993
133. Kothe MJ, Prins JM, de Wit R, et al: Small cell carcinoma of the cervix with inappropriate antidiuretic hormone secretion. Case report. Br J Obstet Gynaecol 97:647-648, 1990
134. Fung SY, Lee KW: Inappropriate antidiuretic hormone secretion associated with adenocarcinoma of endometrium. Case report. Br J Obstet Gynaecol 92:423-425, 1985
135. Fernandez-Miranda C, Mateo S, Gonzalez-Gomez C, et al: Systemic amyloidosis and ovarian carcinoma. Postgrad Med J 70:505-508, 1994
136. Young RH, Scully RE, McCluskey RT: A distinctive glomerular lesion complicating placental site trophoblastic tumor: Report of two cases. Hum Pathol 16:35-42, 1985
137. Hoyt RE, Hamilton JF: Ovarian cancer associated with the nephrotic syndrome. Obstet Gynecol 70:513-514, 1987
138. Freistadt H, Fine MN, Roth RE: Nephrotic syndrome associated with degenerating uterine leiomyoma. West J Med 141:381-382, 1984